The primary aim of this work was to determine the interactions of an oxindole alkaloid (mitraphylline) isolated from Uncaria tomentosa with -amyloid 1-40 (A 1-40 protein) applying the capillary electrophoresis (CE) method. Specifically the Hummel-Dreyer method and Scatchard analysis were performed to study the binding of oxindole alkaloids with A 1-40 protein. Prior to these studies extraction of the alkaloid of interest was carried out. Identification of the isolated alkaloid was performed by the use of thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) combined with electrospray ionization mass spectrometry (ESI-MS). The proposed approach was proved to be an efficient and accurate method for specific compound isolation and identification purposes. Moreover, analytical information from the CE approach can be considered as the valuable tool for binding constant determination. The binding constant of mitraphylline with A 1-40 protein determined by the Hummel-Dreyer method and Scatchard analysis equals K = 9.95 ¥ 10 5 m
Introduction
One of the principal features of Alzheimer disease (AD) is the extracellular deposition of fibrous protein aggregates in the form of amyloid plaques (diffuse, primitive or neuritic). The major component of these deposits is the -amyloid (A ) protein, that is a proteolytic fragment of the integral membrane amyloid precursor protein (APP) (Martin, 1999) . Hence, neurodegenerative changes in the brains of patients suffering from AD are characterized by A protein aggregation. -Amyloid 1-40 (A 1-40 protein) is the main component of the pathological cerebrovascular plaques observed post mortem in the Alzheimer patients. It is a 4.2 kDa protein composed of 39Ð42(43) amino acids. The potential challenge of AD therapy is to find the way to reduce A protein aggregation and then its toxicity. Among several experimental trials, binding of the A protein to different natu-0939Ð5075/2006/1100Ð0821 $ 06.00 " 2006 Verlag der Zeitschrift für Naturforschung, Tübingen · http://www.znaturforsch.com · D ral and synthetic compounds appears as a promising possibility. Identification of such compounds would be of great importance in AD therapy (Honig, 2000) .
It has been reported previously that oxindole alkaloids from the root bark of Uncaria tomentosa prevent A protein aggregation and hence its toxicity. Because of the wide range of pharmacological and biological activities of these compounds, their separations and determinations are of considerable interest. The Alzheimer disease state is characterized by the abnormal accumulation of a normal degradative peptide which becomes resistant to further proteolysis due to conformational changes and then aggregation (Wiśniewski et al., 1993) . Conformational changes of -amyloid from α to structure expose its hydrophobic surface, which allows the -fibrils formation. This process is not spontaneous and depends on pH value, tem-perature, concentration, specific tissue factors, presence of metal ions, and length of the peptide (Uversky and Fink, 2004; Wolozin and Behl, 2000) . Abnormal forms of A protein lead to the neuronal impairment and neuronal death following the neurodegeneration of AD patients. Development of the brain neurodegeneration could be prevented by compounds which inhibit -protein formation, e. g., neurotrofins, non-steroidal anti-inflammatories (NSAD), and alumina chelatic compounds. It has been reported previously that nicotine also prevents A aggregation due to specific binding to the 1Ð28 region of the peptide (Salomon et al., 1996; Moore et al., 2004) . Cotinin, the main metabolite of nicotine in human body, also decreases this process (Salomon et al., 1996; Wang et al., 2000) . Among compounds tested, the indole alkaloids that exist in the bark of Uncaria tomentosa appear potentially active agents to preventamyloid aggregation. In the course of many pharmacological researches, the interaction of alkaloids from Uncaria tomentosa with A protein has been proved by in vitro and in vivo tests. Also the amyloid inhibitory activity of Uncaria tomentosa alkaloids was reported (Castillo and Snow, 2003; Castillo et al., 2005) . Potential therapeutic strategies could explore interactions such as indole alkaloids-A protein in preventing or reversing the initial conformational change of A protein to its pathological -pleated sheet form (Ohara et al., 1995) . A number of very different methods have been developed to measure the ligand-protein parameters. They are mostly based on the bound and free ligand separation in the condition of equilibrium. Among them there are methods like filtration, precipitation, chromatography which may disturb the mutual equilibrium of the constituents (Busch et al., 1997a) . Capillary electrophoresis (CE) has become an important technique for studies of the nature and strength of biological interactions (Š olté s, 2004) . It can be considered as an ideal technique with the prior use of HPLC-MS during the isolation and identification of the compound of interest.
The aim of this research was to examine the binding of a newly identified oxindole alkaloid (mitraphylline) isolated from Uncaria tomentosa to A 1-40 protein followed by the analysis with TLC, HPLC-MS and CE methods, respectively. An established binding measurement method, namely the Hummel-Dreyer approach, was applied to estimate the association constant of the mitraphylline-A protein complex.
Experimental

Materials
Synthetic A protein fragment 1-40 was purchased from Research Biochemical International (Natick, MA, USA). Oxindole alkaloid mitraphylline was isolated from the root bark of Uncaria tomentosa obtained from Peruvian Institute of Andean Phytotherapy (Lima, Peru).
Potassium phosphate monobasic (KH 2 PO 4 ) and sodium phosphate dibasic (Na 2 HPO 4 ) were from Fluka (Buchs, Switzerland). Hydrochloric acid (HCl) and sodium hydroxide (NaOH) were from POCH (Gliwice, Poland). Acetonitrile of chromatographic quality was from Merck (Darmstadt, Germany) and trifluoroacetic acid (TFA) was from Sigma-Aldrich (St. Louis, MO, USA). Water was prepared with a Mili-Q system (Millipore, Bedford, MA, USA).
Plant material extraction
1 kg of powdered bark was moistened with distilled water and left for 3 h in an encapsulated vessel. Afterwards, such a moistened bark was put into a mixing rotary extractor. The extraction was carried out three times during 3 h with the use of 1,1,2-trichloroethylene at a temperature of 35Ð 40 ∞C, where 9 L of 1,1,2-trichloroethylene were needed for each extraction. The obtained extracts were then combined and distilled at reduced pressure. The dry remains were dissolved in methanol at 40Ð45 ∞C. A precipitate appeared after cooling the solution to room temperature and was then filtered. Next it was rinsed through a filter with methanol. The filtrate, now lacking lipophilic substances, was condensed and the obtained precipitate was recrystallized in boiling methanol. The compound gained in the form of white crystal needles (50 mg) was left for further identification studies.
Sample preparation prior to binding measurements with the use of capillary electrophoresis method
Lyophilized A protein was kept frozen at -20 ∞C. Before the experiments the sample of A protein was warmed up to room temperature. 1 mg of A protein was dissolved in 1 mL of dis-tilled and deionized water. Then the solution of A protein was divided into 0.1 mL portions at a concentration of 230 μm and frozen. For the binding procedure A protein at a concentration of 46 μm was prepared using 0.022 m phosphate buffer, pH 5. 6.
The sample of 2.3 mg mitraphylline was dissolved in 3 mL of methanol. Then several dilutions of mitraphylline within the concentration range from 10 to 62.5 μm were prepared in 0.022 m phosphate buffer, pH 5.6.
Thin-layer chromatography experiments
TLC experiments were performed on precoated silica gel Si 60 F 254 glass plates, ready-made by Merck. Chromatograms on 10 ¥ 10 ¥ 0.2 cm plates were developed to a distance of 9.0 cm in a horizontal DS chamber (Chromdes, Lublin, Poland) at room temperature. The plates were spotted with 5Ð15 μL of 0.5% solutions of extract and examined fraction in methanol. The mobile phases used for normal-phase chromatography were chloroform/acetone 5 : 4 (v/v) (mobile phase I), chloroform/ethanol 95 : 5 (v/v) (mobile phase II) and ethyl acetate/isopropanol/ammonia 100 : 2 :1 (v/v) (mobile phase III). The developed plates were dried in the air at room temperature. Chromatograms were visualized by illumination with UV light (λ = 254 nm) and after treatment with Dragendorff reagent they gave orange or brown, usually stable bands in visible light.
HPLC-MS analysis
Chromatographic separation was done on a Shimadzu HPLC (Shimadzu, Kyoto, Japan) system consisting of two pumps (LC-10 AD and LC-10 AD VP ), UV detector (SPD-10 A), autosampler (SIL-10 AD VP ), column oven (CTD-10 AD VP ) and system controller (SCL-10 AD VP ) with a 35 μL injection loop. The alkaloid was separated on a LiChrospher RP (5 μm) column, 250 ¥ 4 mm I. D. (Merck) prior to MS analysis. The separation was performed with the use of isocratic elution with a mobile phase comprised of water with the addition of 0.1% TFA and acetonitrile with the addition of 0.1% TFA in the proportion of 90 :10 (v/v). The elution was carried out at room temperature with a flow rate of 1 mL/min and UV detection set at 254 nm.
Confirmation of the identity of the alkaloid of interest was done with the use of electrospray ionization mass spectrometry (ESI-MS). Mass spectra in ESI-MS method were recorded on a Finningan MAT TSQ 700 triple-stage quadrupole mass spectrometer equipped with an electrospray (ESI) ion source. The ion spray needle was maintained at 4.5 kV. Nitrogen gas was used to evaporate the solvent from the charged droplets.
Capillary electrophoresis analysis
Capillary electrophoresis was performed on a Waters Quanta 4000E capillary electrophoresis system (Millipore Corp., Milford, MA, USA). Uncoated fused-silica capillaries from J&W Scientific Inc. (Folsom, CA, USA) of 50 μm I. D., 375 μm O. D. and 61 cm total length were used. All runs were at a fixed temperature of 20 ∞C in a 0.022 m phosphate buffer, pH 5.6, with an applied voltage of 20 kV. Samples were introduced by means of the 10 s hydrostatic injection method. The detection was at the cathodic end. The wavelength of the UV detector was adjusted to 254 nm.
Before each electrophoretic experiment the capillary was flushed for 2 min with 0.1 m HCl and 0.1 m NaOH, following for another 4Ð6 min with 0.022 m phosphate buffer, pH 5.6. The buffer solution was filtered through Minisart 0.2 μm filters from Sartorius AG (Göttingen, Germany).
Procedures and calculations
The 0.022 m phosphate buffer, pH 5.6, was prepared daily by mixing appropriate amounts of KH 2 PO 4 and Na 2 HPO 4 in 250 mL distilled water. A protein sample was stored at -20 ∞C. The A protein and mitraphylline samples were diluted with 0.022 m phosphate buffer, pH 5.6, prior to the analysis.
To calculate properly the binding parameters of mitraphylline alkaloid, 5Ð6 data points of the mitraphylline-A isotherm are required. In all studies the A concentration was kept constant at the level of 46 μm. The mitraphylline concentration was varied according to the following scheme: 10, 15, 20, 30, 50, 62.5 ¥ 10 -6 m. The data obtained experimentally were subjected to the analysis by the Scatchard method (Table I) . Scatchard method is a commonly used strategy to determine binding parameters in various drug-protein systems. It is based on the measurement of the total fraction of drug bound by a fixed amount of protein, r, as a function of the concentration of the drug that remains free in the Table I . Experimental data along with the binding parameters of the mitraphylline-A protein complex used in the studies. solutions, D f . Taking into consideration the descending, linear part of the Scatchard curve, the apparent association constant, K (m -1 ), of mitraphylline-A complexes was determined (Fig. 2) .
Results and Discussion
Alkaloid identification
Basing on TLC chromatography and HPLC-ESI-MS analysis, it has been stated that the compound isolated from Uncaria tomentosa is mitraphylline, which is a pentacyclic oxindole alkaloid. After the HPLC-ESI-MS experiment, MS spectrum analysis allowed to identify unambiguously the molecular ion signal at m/z = 368.9. An intensive fragmented ion occurs during the disintegration of the alicyclic part of the alkaloid. Consequently loosing a methyl group at C-19, it forms a succeeding ion.
Binding measurements
The description of reversible drug-protein binding was based on the multiple equilibrium theory (Klotz and Hunston, 1971; Feldman, 1972) expressed by the following equation:
where r is the mean number of drug molecules bound per protein molecule, m is the number of classes of independent binding sites, [D b ], [D f ] and [P total ] are the concentration of bound drug, free drug and total protein, respectively, n i is the number of binding sites of class i and K i is their corresponding association (binding) constant.
Binding constant measurements were based on the Hummel-Dreyer method (Hummel and Dreyer, 1962) . In electrophoretic applications of that method (Busch et al., 1997b) , the capillary was filled with a buffer containing the drug. Then a small amount of sample, which contained the buffer, the drug and the protein, was injected into the capillary. When the electrophoresis started, the components of sample plug migrated with their own mobility in the direction of the detector. On the electropherogram (Fig. 1b) a positive peak appeared which corresponded to the ligand-protein complex and to the free protein. The negative peak emerged at the migration time of the ligand and the area of that peak was directly related to the amount of ligand bound to the protein, [D b ] (Busch et al., 1997b) . The amount of bound ligand was quantified from an external calibration (Sebille et al., 1978; Kraak et al., 1992) .
In the external calibration method, calculations were based on differences of the total area obtained upon injecting the protein sample and the total area obtained when plane buffer was injected. The concentration of the free ligand, [D f ], could be set as equal to the concentration of the ligand in the buffer, (Busch et al., 1997b; Kraak et al., 1992) . Hence, the following relationship holds:
where A p is the area of the sample peak, A e is the area of the buffer peak. Adsorption of the proteins onto the fused-silica capillary wall may influence the determination of the binding parameters. Adsorption of the proteins resulted from the attractive electrostatic interactions between positively charged regions of the proteins and negative charges present on the fused-silica capillary wall. This led to poor peak shapes, low resolution, incomplete recoveries and irreproducible separations. The deformed protein peaks presented in electropherograms (Fig. 1) could not be attributed only to adsorption and arose due to the slow kinetics of the complexation as was also con- firmed by Busch et al. (1997b) and Avila et al., (1993) . Especially in the Hummel-Dreyer method, the multiple or deformed positive peaks due to protein and protein-ligand complex were not of interest because in calculations only the areas of negative peaks were considered (Sebille et al., 1978) .
The Scatchard plot (r/D f vs. r) derived from the experimental data for mitraphylline and A protein binding complex measured by the Hummel-Dreyer method is given in Fig. 2 . The shape of that Scatchard plot suggests one class binding character of the analyzed interaction. Binding constants of mitraphylline and alkaloid-A protein have been estimated based on the slopes of linear regression equations derived from the descending three data points of the Scatchard plot. Hence, the binding constant for the mitraphylline-A protein complex is K = 9.95 ¥ 10 -5 m -1 . Fig. 3 shows a typical adsorption isotherm for the corresponding Scatchard plot as measured by the Hummel-Dreyer method for the interaction between the mitraphylline alkaloid and the A protein. As it can be seen, the isotherm looks accept- able but the points, especially at higher r values, do not fit the non-linear regression line. It can be supposed that this feature reflects non-specific interactions between mitraphylline and the A protein complex.
